GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Novartis India Ltd

Novartis India Board Notes Novartis AG Share Sale Completion

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 29 Jul 2026, 08:17 PM IST  ·  BSE ID: 8a3f050c-a531-47ce-83a3-0aa3a424c115
View Original BSE Filing (PDF)
💡
In Simple Terms
Novartis India's board acknowledged the sale of over 17 million company shares by Novartis AG to ChrysCapital.
🤖 AI Summary
  • Board notes Novartis AG sold 17,450,680 equity shares.
  • Sale completed to ChrysCapital entities on July 29, 2026.
  • Transaction follows sale and purchase agreement dated February 19, 2026.
  • Board acknowledged the completion of this significant share transfer.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Sold
17,450,680
🏢 How This Affects the Company
📈
Business Impact
The completion of the share sale signifies a change in the principal ownership of Novartis India Limited, transitioning from Novartis AG to ChrysCapital entities.
💰
Financial Impact
This event marks a completed transaction involving a significant block of shares, affecting the beneficial ownership structure of the company.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this board acknowledgment.
👤
Who Is Affected
Shareholders are affected by the confirmed change in controlling ownership from Novartis AG to ChrysCapital entities.
🔍
Management Signal
The board's acknowledgment signals acceptance and formal recording of a significant change in the company's ownership structure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future announcements from ChrysCapital on strategic plans.
Any changes in board composition post-acquisition.
Company's future financial disclosures under new ownership.
LOW RISK The filing is a factual update on a completed transaction, not introducing new immediate risks.
💡 Investor Takeaway
Novartis India's Board confirmed Novartis AG's sale of 17,450,680 equity shares to ChrysCapital entities on July 29, 2026, completing the transaction.
❓ Frequently Asked Questions
What significant event did Novartis India's Board acknowledge on July 29, 2026?
The Board acknowledged the completion of Novartis AG's sale of 17,450,680 equity shares to ChrysCapital entities.
How many equity shares were sold by Novartis AG?
Novartis AG sold 17,450,680 equity shares of Novartis India Limited.
Who acquired the shares from Novartis AG?
The shares were acquired by ChrysCapital entities, including WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners.
When was the sale and purchase agreement for these shares signed?
The agreement for the sale and purchase of the shares was signed on February 19, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.